Sol-Gel’s stock jumps 90% on positive acne-drug studies
December 30, 2019 at 10:51 AM EST
Shares of Sol-Gel Technologies Ltd. gained 81% in morning trading on Monday after the Israeli drugmaker said its acne drug Twyneo met the primary endpoints in two late-stage trials.
